Financhill
Back

BioMarin Pharmaceutical, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$60.85
Seasonality Move:
5.52%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

BioMarin Pharmaceutical, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 54.3 Buy
20-day SMA: 54.44 Buy
50-day SMA: 53.75 Buy
200-day SMA: 57.88 Buy
8-day EMA: 55.52 Buy
20-day EMA: 54.49 Buy
50-day EMA: 54.3 Buy
200-day EMA: 58.29 Buy

BioMarin Pharmaceutical, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.58 Buy
Relative Strength Index (14 RSI): 65.44 Buy
Chaikin Money Flow: -3219403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.13 - 56.45) Buy
Bollinger Bands (100): (52.65 - 57.47) Buy

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for BioMarin Pharmaceutical, Inc. Stock

Is BioMarin Pharmaceutical, Inc. Stock a Buy?

BMRN Technical Analysis vs Fundamental Analysis

Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy or a Sell?

BioMarin Pharmaceutical, Inc. Stock Info

Market Cap:
11.4B
Price in USD:
59.28
Share Volume:
5.3M

BioMarin Pharmaceutical, Inc. 52-Week Range

52-Week High:
73.51
52-Week Low:
50.76
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

BioMarin Pharmaceutical, Inc. Share Price Forecast

Is BioMarin Pharmaceutical, Inc. Stock a Buy?

Fundamental Analysis of BioMarin Pharmaceutical, Inc.

Is BioMarin Pharmaceutical, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.73 per share.

Technical Analysis of BioMarin Pharmaceutical, Inc.

Should I short BioMarin Pharmaceutical, Inc. stock?

* BioMarin Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.